Literature DB >> 27437650

Association of Maternal Prepregnancy Dyslipidemia With Adult Offspring Dyslipidemia in Excess of Anthropometric, Lifestyle, and Genetic Factors in the Framingham Heart Study.

Michael M Mendelson1, Asya Lyass2, Christopher J O'Donnell3, Ralph B D'Agostino2, Daniel Levy4.   

Abstract

IMPORTANCE: Dyslipidemia in young adults in the United States during their childbearing years is common, and the consequences for the next generation are poorly understood. Further understanding of the harmful consequences of elevated low-density lipoprotein cholesterol (LDL-C) levels in young adults may help to inform population screening and management strategies.
OBJECTIVE: To examine whether adult levels of serum LDL-C are associated with maternal prepregnancy LDL-C levels beyond that attributable to inherited genetic sequence polymorphisms, diet, physical activity, and body mass index. DESIGN, SETTING, AND PARTICIPANTS: The Framingham Heart Study is a multigenerational, population-based inception cohort initiated in 1948 in Framingham, Massachusetts. In this study of families, the analyses included 538 parent-offspring pairs with parental LDL-C levels measured in the study prior to the offspring's birth. Parental prebirth, parental concurrent, and adult offspring assessments occurred in 1971-1983, 1998-2001, and 2002-2005, respectively. Data analyses were conducted between March 1, 2013, and May 30, 2015. EXPOSURES: Maternal prepregnancy LDL-C levels compared with paternal prepregnancy and parental concurrent LDL-C levels in association with adult offspring LDL-C levels. MAIN OUTCOMES AND MEASURES: Adult offspring LDL-C levels were examined as both a continuous and dichotomous outcome (using a threshold of 130 mg/dL).
RESULTS: Among the 538 parent-offspring pairs, there were 241 mother-offspring and 297 father-offspring pairs with a mean (SD) offspring age of 26 (3) years. Adult offspring LDL-C levels were associated with maternal prepregnancy LDL-C levels after adjustment for family relatedness and offspring lifestyle, anthropometric factors, and inherited genetic variants (β = 0.32 [SE, 0.05] mg/dL; P < .001). After multivariable adjustment, adults who had been exposed to elevated maternal prepregnancy LDL-C levels were at a 3.8 (95% CI, 1.5-9.8) times higher odds of having elevated LDL-C levels (P = .005) and had an adjusted LDL-C level of 18 mg/dL (95% CI, 9-27 mg/dL) higher than did those without such exposure. Maternal prepregnancy LDL-C levels explained 13% of the variation in adult offspring LDL-C levels beyond common genetic variants and classic risk factors for elevated LDL-C levels. CONCLUSIONS AND RELEVANCE: Adult offspring dyslipidemia is associated with maternal prepregnancy dyslipidemia in excess of measured lifestyle, anthropometric, and inherited genetic factors. The findings support the possibility of a maternal epigenetic contribution to cardiovascular disease risk in the general population. Further research is warranted to determine whether ongoing public health efforts to identify and reduce dyslipidemia in young adults prior to their childbearing years may have additional potential health benefits for the subsequent generation.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27437650      PMCID: PMC6391057          DOI: 10.1001/jamacardio.2015.0304

Source DB:  PubMed          Journal:  JAMA Cardiol            Impact factor:   14.676


  45 in total

Review 1.  Maternal hypercholesterolemia during pregnancy influences the later development of atherosclerosis: clinical and pathogenic implications.

Authors:  C Napoli; W Palinski
Journal:  Eur Heart J       Date:  2001-01       Impact factor: 29.983

2.  Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III).

Authors: 
Journal:  JAMA       Date:  2001-05-16       Impact factor: 56.272

Review 3.  Quantifying effect of statins on low density lipoprotein cholesterol, ischaemic heart disease, and stroke: systematic review and meta-analysis.

Authors:  M R Law; N J Wald; A R Rudnicka
Journal:  BMJ       Date:  2003-06-28

4.  The NCBI dbGaP database of genotypes and phenotypes.

Authors:  Matthew D Mailman; Michael Feolo; Yumi Jin; Masato Kimura; Kimberly Tryka; Rinat Bagoutdinov; Luning Hao; Anne Kiang; Justin Paschall; Lon Phan; Natalia Popova; Stephanie Pretel; Lora Ziyabari; Moira Lee; Yu Shao; Zhen Y Wang; Karl Sirotkin; Minghong Ward; Michael Kholodov; Kerry Zbicz; Jeffrey Beck; Michael Kimelman; Sergey Shevelev; Don Preuss; Eugene Yaschenko; Alan Graeff; James Ostell; Stephen T Sherry
Journal:  Nat Genet       Date:  2007-10       Impact factor: 38.330

5.  Maternal hypercholesterolemia during pregnancy promotes early atherogenesis in LDL receptor-deficient mice and alters aortic gene expression determined by microarray.

Authors:  Claudio Napoli; Filomena de Nigris; John S Welch; Federico B Calara; Robert O Stuart; Christopher K Glass; Wulf Palinski
Journal:  Circulation       Date:  2002-03-19       Impact factor: 29.690

6.  Maternal hypercholesterolemia and treatment during pregnancy influence the long-term progression of atherosclerosis in offspring of rabbits.

Authors:  W Palinski; F P D'Armiento; J L Witztum; F de Nigris; F Casanada; M Condorelli; M Silvestre; C Napoli
Journal:  Circ Res       Date:  2001-11-23       Impact factor: 17.367

7.  The Third Generation Cohort of the National Heart, Lung, and Blood Institute's Framingham Heart Study: design, recruitment, and initial examination.

Authors:  Greta Lee Splansky; Diane Corey; Qiong Yang; Larry D Atwood; L Adrienne Cupples; Emelia J Benjamin; Ralph B D'Agostino; Caroline S Fox; Martin G Larson; Joanne M Murabito; Christopher J O'Donnell; Ramachandran S Vasan; Philip A Wolf; Daniel Levy
Journal:  Am J Epidemiol       Date:  2007-03-19       Impact factor: 4.897

Review 8.  Maternal cholesterol in fetal development: transport of cholesterol from the maternal to the fetal circulation.

Authors:  Laura A Woollett
Journal:  Am J Clin Nutr       Date:  2005-12       Impact factor: 7.045

9.  Maternal hypercholesterolemia enhances atherogenesis in normocholesterolemic rabbits, which is inhibited by antioxidant or lipid-lowering intervention during pregnancy: an experimental model of atherogenic mechanisms in human fetuses.

Authors:  C Napoli; J L Witztum; F Calara; F de Nigris; W Palinski
Journal:  Circ Res       Date:  2000-11-10       Impact factor: 17.367

10.  Intrauterine exposure to maternal atherosclerotic risk factors increases the susceptibility to atherosclerosis in adult life.

Authors:  Fanneke E Alkemade; Adriana C Gittenberger-de Groot; Anja E Schiel; J Conny VanMunsteren; Bianca Hogers; Leontien S J van Vliet; Robert E Poelmann; Louis M Havekes; Ko Willems van Dijk; Marco C DeRuiter
Journal:  Arterioscler Thromb Vasc Biol       Date:  2007-07-26       Impact factor: 8.311

View more
  13 in total

1.  Maternal hypercholesterolemia programs dyslipidemia in adult male mouse progeny.

Authors:  Joyce Mathew; Sze-Chi Huang; Jerad H Dumolt; Mulchand S Patel; Todd C Rideout
Journal:  Reproduction       Date:  2020-07       Impact factor: 3.906

2.  Epigenetic Hallmarks of Fetal Early Atherosclerotic Lesions in Humans.

Authors:  Filomena de Nigris; Francesco Cacciatore; Francesco P Mancini; Dino F Vitale; Gelsomina Mansueto; Francesco P D'Armiento; Concetta Schiano; Andrea Soricelli; Claudio Napoli
Journal:  JAMA Cardiol       Date:  2018-12-01       Impact factor: 14.676

3.  Malprogramming of Hepatic Lipid Metabolism due to Excessive Early Cholesterol Exposure in Adult Progeny.

Authors:  Jerad H Dumolt; Richard W Browne; Mulchand S Patel; Todd C Rideout
Journal:  Mol Nutr Food Res       Date:  2018-11-26       Impact factor: 5.914

4.  Epigenetics of Lipid Phenotypes.

Authors:  Sergi Sayols-Baixeras; Marguerite R Irvin; Donna K Arnett; Roberto Elosua; Stella W Aslibekyan
Journal:  Curr Cardiovasc Risk Rep       Date:  2016-08-31

5.  Gestational hypercholesterolemia alters fetal hepatic lipid metabolism and microRNA expression in Apo-E-deficient mice.

Authors:  Jerad H Dumolt; Min Ma; Joyce Mathew; Mulchand S Patel; Todd C Rideout
Journal:  Am J Physiol Endocrinol Metab       Date:  2019-08-27       Impact factor: 4.310

Review 6.  The effects of omega-3 fatty acids supplementation on metabolic status in pregnant women: a systematic review and meta-analysis of randomized controlled trials.

Authors:  Elaheh Amirani; Zatollah Asemi; Omid Asbaghi; Alireza Milajerdi; Željko Reiner; Mohammad Ali Mansournia; Jamal Hallajzadeh; Bahram Moazzami; Shahla Chaichian
Journal:  J Diabetes Metab Disord       Date:  2020-06-06

7.  Novel associations between parental and newborn cord blood metabolic profiles in the Norwegian Mother, Father and Child Cohort Study.

Authors:  Linn K L Øyri; Martin P Bogsrud; Jacob J Christensen; Stine M Ulven; Anne Lise Brantsæter; Kjetil Retterstøl; Hilde K Brekke; Trond M Michelsen; Tore Henriksen; Jeanine E Roeters van Lennep; Per Magnus; Marit B Veierød; Kirsten B Holven
Journal:  BMC Med       Date:  2021-04-14       Impact factor: 8.775

Review 8.  Evaluation and management of blood lipids through a woman's life cycle.

Authors:  Jyoti Sharma; Jan McAlister; Niti R Aggarwal; Janet Wei; Puja K Mehta; Odayme Quesada; Deirdre Mattina; Nandita S Scott; Erin D Michos; Zainab Mahmoud; Karla Kurrelmeyer; Glaucia Maria Moraes De Oliveira; Kathryn J Lindley
Journal:  Am J Prev Cardiol       Date:  2022-03-13

Review 9.  Excessive early-life cholesterol exposure may have later-life consequences for nonalcoholic fatty liver disease.

Authors:  Jerad H Dumolt; Mulchand S Patel; Todd C Rideout
Journal:  J Dev Orig Health Dis       Date:  2020-04-15       Impact factor: 2.401

10.  Maternal supraphysiological hypercholesterolemia associates with endothelial dysfunction of the placental microvasculature.

Authors:  Bárbara Fuenzalida; Bastián Sobrevia; Claudette Cantin; Lorena Carvajal; Rocío Salsoso; Jaime Gutiérrez; Susana Contreras-Duarte; Luis Sobrevia; Andrea Leiva
Journal:  Sci Rep       Date:  2018-05-16       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.